10-Q: Coty Reports Q2 Loss Amid Wella Sale, Leadership Transition

Coty Inc. reported a net loss for the second fiscal quarter and first half of 2026, driven by the sale of its remaining Wella stake and declining revenues across key segments, alongside a significant leadership change.

Summary

• Coty Inc. reported a net loss attributable to Coty Inc. of $123.6 million for the three months ended December 31, 2025, compared to a net income of $23.7 million in the prior-year period.
• For the six months ended December 31, 2025, the net loss attributable to Coty Inc. was $55.7 million, a significant decline from a net income of $106.6 million in the same period last year.
• Net revenues for the three months ended December 31, 2025, increased by 1% to $1,678.6 million, but decreased by 3% to $3,255.8 million for the six months ended December 31, 2025.
• Gross profit decreased by 3.9% for the quarter and 5.5% for the six months, with gross margin declining by 290 basis points and 200 basis points, respectively, primarily due to increased manufacturing and material costs, freight, designer license fees, and higher discounts/promotions.
• Operating income fell by 45% for the quarter to $148.2 million and by 34% for the six months to $333.2 million, with operating margins decreasing significantly.
• The company completed the sale of its remaining 25.8% equity interest in Wella on December 18, 2025, receiving $750.0 million in cash and Wella Distribution Rights valued at $58.0 million, but recognized a loss on sale of $201.9 million.
• Markus Strobel was appointed Executive Chairman and Interim Chief Executive Officer, effective January 1, 2026, following Sue Nabi's departure as CEO on December 31, 2025.
• Coty issued $900.0 million of 5.600% senior notes due 2031 and used proceeds to redeem $350.0 million of 2026 Dollar Senior Secured Notes and 450.0 million Euro (approximately $526.8 million) of 2026 Euro Senior Secured Notes.
• Proceeds from the Wella sale were used to redeem 500.0 million Euro (approximately $588.9 million) of 2028 Euro Senior Secured Notes.
• The company expects its operating results to be impacted by approximately $33.0 million in costs related to tariff increases through Q1 fiscal 2027, with $14.0 million already reflected in the first half of fiscal 2026.
• Net cash provided by operating activities increased to $624.9 million for the six months ended December 31, 2025, from $531.9 million in the prior year, driven by working capital changes.
• Net cash provided by investing activities significantly improved to $658.7 million from a use of $108.2 million, primarily due to the Wella sale proceeds.
• Net cash used in financing activities increased to $1,106.5 million from $461.3 million, mainly due to debt-related activities and higher payments for hedge valuation adjustments on forward repurchase contracts.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing negatively due to significant net losses, declining operating income, and gross margin pressure, despite positive debt reduction efforts. The ongoing strategic review and challenging market conditions contribute to uncertainty.

Positives

• Net cash provided by operating activities increased by $93.0 million to $624.9 million for the six months ended December 31, 2025, compared to the prior year.
• Net cash provided by investing activities significantly improved to $658.7 million for the six months ended December 31, 2025, primarily due to the $750.0 million cash proceeds from the Wella equity sale.
• Interest expense, net, decreased by 24% for both the three and six months ended December 31, 2025, primarily due to foreign exchange gains and positive impact from cross-currency swaps reducing interest expense.
• The company successfully issued $900.0 million in new senior notes and used proceeds, along with Wella sale proceeds, to redeem approximately $1.46 billion in existing senior secured notes, optimizing its debt maturity profile and reducing overall debt.
• The effective income tax rate decreased to 31.1% for the three months and 31.4% for the six months ended December 31, 2025, primarily due to the release of uncertain tax positions and a benefit from the Wella sale.
• Prestige fragrance sales showed growth for Gucci and Kylie fragrances, benefiting from innovations and new launches in the three months ended December 31, 2025.

Negatives

• Coty reported a net loss attributable to Coty Inc. of $123.6 million for the three months and $55.7 million for the six months ended December 31, 2025, a significant decline from net income in the prior periods.
• Diluted earnings per common share were $(0.14) for the quarter and $(0.07) for the six months, compared to positive EPS in the prior periods.
• Gross profit decreased by 3.9% for the quarter and 5.5% for the six months, with gross margin declining by 290 basis points and 200 basis points, respectively, due to increased costs and higher discounts/promotions.
• Operating income decreased by 45% for the quarter and 34% for the six months, reflecting significant pressure on profitability.
• The Consumer Beauty segment experienced substantial declines in operating income, down 71% for the quarter and 86% for the six months, driven by increased cost of goods sold and operational accruals.
• Net revenues for the six months ended December 31, 2025, decreased by 3%, with declines across Prestige (-1%) and Consumer Beauty (-5%) segments, and across all geographic regions (Americas, EMEA, Asia Pacific).
• Color cosmetics sales declined by a mid-single-digit percentage in the first half of fiscal 2026, primarily due to weak demand in the U.S. market and market share losses.
• Mass fragrance sales declined due to a deceleration of the overall mass fragrance market and an expired license agreement.
• The company recognized a $201.9 million loss on the sale of its remaining Wella equity interest.
• Selling, general and administrative expenses increased by 6% for the quarter and 2% for the six months, contributing to operating income pressure.
• The company paid $85.6 million in Hedge Valuation Adjustments related to forward repurchase contracts during the six months ended December 31, 2025, due to declines in Coty's Class A Common Stock price.
• The financial outlook for Q3 fiscal 2026 anticipates a decline in reported net revenue and pressured gross margin due to lower net sales and tariff impacts.

Risks

• Ability to successfully implement strategic priorities, achieve benefits from initiatives (revenue growth, cost control, gross margin growth, debt deleveraging), and compete effectively in the beauty industry, in each case within the expected time frame or at all.
• Anticipating, gauging, and responding to rapidly changing market trends and consumer preferences, and the market acceptance of new products, including new products in skincare and prestige cosmetics portfolios, any relaunched or rebranded products and the anticipated costs and discounting associated with such relaunches and rebrands.
• Use of estimates and assumptions in preparing financial statements, including with regard to revenue recognition, income taxes, the assessment of goodwill, other intangible and long-lived assets for impairments, and the market value of inventory.
• Managerial, transformational, operational, regulatory, legal and financial risks, including diversion of management attention to and management of cash flows, expenses and costs associated with the transformation agenda, global business strategies, and strategic partnerships.
• Increased competition, consolidation among retailers, shifts in consumers preferred distribution and marketing channels (including to digital and prestige channels), distribution and shelf-space resets or reductions, and other changes in the retail, e-commerce and wholesale environment.
• Dependence on certain licenses (especially in the fragrance category) and ability to renew expiring licenses on favorable terms or at all.
• Dependence on entities performing outsourced functions, including distribution, and third-party manufacturers, logistics and supply chain suppliers.
• Administrative, product development and other difficulties in meeting the expected timing of market expansions, product launches, re-launches and marketing efforts.
• Changes in the demand for products due to declining or depressed global or regional economic conditions, and declines in consumer confidence or spending, whether related to the economy, wars and other hostilities, natural disasters, or security concerns.
• Global political and/or economic uncertainties, disruptions or major regulatory or policy changes, and/or the enforcement thereof that affect the business, financial performance, operations or products, including the impact of the war in Ukraine, armed conflict in the Middle East, changes in U.S. tax code and/or tax regulations in other jurisdictions, and recent and future changes in tariffs, trade policies and other international trade regulations.
• Currency exchange rate volatility and currency devaluation and/or inflation.
• Ability to implement and maintain pricing actions to effectively mitigate increased costs and inflationary pressures, and the reaction of customers or consumers to such pricing actions.
• The number, type, outcomes (by judgment, order or settlement) and costs of current or future legal, compliance, tax, regulatory or administrative proceedings, investigations and/or litigation, including product liability cases (such as asbestos and talc-related litigation) and Brazilian tax assessments.
• Disruptions in the availability and distribution of raw materials and components needed to manufacture products, and ability to effectively manage production and inventory levels in response to supply challenges.
• Increasing dependency on information technology, including as a result of remote working practices, and ability to protect against service interruptions, data corruption, cyber-based attacks or network security breaches.
• Ability to attract and retain key personnel and the impact of senior management transitions.
• The distribution and sale by third parties of counterfeit and/or gray market versions of products.
• Relationship with JAB Beauty B.V., as majority stockholder, and its affiliates, and any related conflicts of interest or litigation.
• Future sales of a significant number of shares by the majority stockholder or the perception that such sales could occur.

Future Outlook

Coty expects reported net revenue for the third quarter of fiscal 2026 to decline compared to the prior year, despite an estimated low to mid-single-digit percentage benefit from foreign exchange. Gross margin is anticipated to be pressured by lower net sales and the net impact from tariffs. The company is re-accelerating cost reduction efforts to achieve approximately $80.0 million in savings in fiscal 2026. Management is undertaking a comprehensive review of the business to assess opportunities for enhanced performance, competitive positioning, and execution, with updates expected through future filings. Common stock dividends remain suspended until the company approaches a Net debt to Adjusted EBITDA target of 2x.

Management Comments

• Markus Strobel, Executive Chairman and Interim Chief Executive Officer, is undertaking a comprehensive review of the business to assess opportunities to enhance performance, strengthen competitive positioning, and improve execution across key areas.
• Management believes that the outcome of current Legal Proceedings will not have a material effect upon its business, prospects, financial condition, results of operations, cash flows or the trading price of the Company's securities, but acknowledges that settlement values and other costs associated with cosmetic talcum powder cases are likely to increase in the future.
• Management believes it has meritorious defenses against Brazilian tax assessments and does not believe a loss is probable for these assessments.

Industry Context

StockSavvy.ai notes that Coty's performance reflects broader challenges in the beauty industry, particularly in mass market segments and certain geographic regions. The decline in color cosmetics, especially in the U.S., aligns with shifts in consumer preferences and competitive pressures. While prestige fragrance showed some growth for specific brands, the overall moderating category growth and elevated promotional intensity indicate a challenging market. The strategic review by the new Interim CEO suggests a potential pivot or re-prioritization to address these market dynamics and improve profitability, aligning with industry trends towards efficiency and targeted growth in structurally profitable categories like skincare.

Comparison to Industry Standards

• The decline in Coty's Consumer Beauty segment, with operating income down 71% for the quarter, contrasts with some competitors who have shown resilience or growth in mass beauty through strong digital engagement and product innovation. For example, L'Oréal's Consumer Products division, while facing some headwinds, has generally maintained stronger profitability and market share through continuous innovation and robust e-commerce strategies.
• Coty's Prestige segment, despite a 2% revenue increase in Q2, saw operating income decline by 18%. This indicates a struggle to translate revenue growth into profit, possibly due to promotional activities or increased costs. Luxury beauty brands like Estée Lauder or LVMH's beauty divisions often demonstrate stronger operating leverage in their prestige segments, even with similar revenue growth, by maintaining premium pricing and efficient cost structures.
• The significant gross margin pressure (down 290 bps in Q2) due to manufacturing, material, and freight costs, along with higher discounts, suggests Coty is facing greater supply chain and pricing challenges compared to some peers who have more effectively passed on costs or optimized their supply chains. Companies like Procter & Gamble (with brands like Olay) have often demonstrated stronger pricing power and supply chain resilience in similar inflationary environments.

Management Changes

Corporate Governance

Legal Proceedings

• The company is involved in various litigation, administrative, and other legal proceedings, including consumer class actions, personal injury (talc-based cosmetic products alleging asbestos contamination), intellectual property, competition, compliance, and advertising claims.
• Cosmetic Talcum Powder Matters: The company is a defendant in numerous civil actions alleging asbestos contamination in talc-based cosmetic products. While past settlements were not material, the rising number of cases and evolving litigation landscape suggest settlement values and costs are likely to increase. The company believes a limited portion of costs will be covered by insurance.
• Brazilian Tax Assessments: Brazilian subsidiaries face tax assessments totaling approximately R$1,803.7 million (approximately $376.0 million as of December 31, 2025) for state sales tax credits (ICMS) and federal excise taxes (IPI) from 2016-2020. The company has provided surety bonds of R$1,088.9 million (approximately $198.7 million) and cash deposits of R$212.7 million (approximately $38.8 million) to guarantee payment if cases are resolved against it.
• The company believes it has meritorious defenses against the Brazilian tax assessments and has not recognized a loss, as a loss is not considered probable. The range of reasonably possible losses in excess of accrued liabilities currently cannot be reasonably estimated for talc litigation.

Related Party Transactions

• Performance Guarantee: The company is secondarily liable for a real estate lease assigned to JAB Partners LLP, with a maximum potential future payment of approximately $2.9 million if the assignee defaults. The probability of default is assessed as remote.
• Wella: The agreement to provide management, consulting, and financial services to Wella ended on December 18, 2025, following the sale of the remaining equity interest. Fees earned were $0.4 million for the three months and $0.7 million for the six months ended December 31, 2025. Manufacturing arrangements with Wella continue, with fees earned of $1.0 million for the three months and $2.6 million for the six months ended December 31, 2025.
• Secondment Agreement: On October 1, 2025, the company entered into a secondment arrangement with an entity affiliated with JAB to obtain executive management services, incurring a fixed fee of $0.3 million for the quarter ended December 31, 2025.

Stakeholder Impact

• Shareholders: Experience a significant net loss and negative EPS, indicating reduced profitability. The suspension of common stock dividends continues, impacting shareholder returns. The Wella sale and debt reduction efforts aim to improve long-term financial health and deleveraging, which could benefit shareholders in the future.
• Employees: The Fixed Cost Reduction Plan and ongoing restructuring actions may lead to job reductions or changes in roles, impacting employee morale and stability. The change in CEO and subsequent strategic review could also create uncertainty.
• Customers: Declining net revenues in key segments like color cosmetics and mass fragrance, along with increased promotional activity, suggest competitive pressures and potential shifts in customer preferences. Tariff impacts could lead to price adjustments, affecting customer purchasing decisions.
• Creditors: The company's active debt reduction and refinancing efforts, including the use of Wella sale proceeds, improve its leverage profile and debt maturity schedule, which is positive for creditors. Compliance with debt covenants is maintained.
• Suppliers: Supply chain optimization efforts, including diversified sourcing strategies and regionalization, may lead to changes in supplier relationships and demand patterns.

Next Steps

• Markus Strobel, as Interim CEO, will undertake a comprehensive review of the business to assess opportunities for enhanced performance, competitive positioning, and improved execution.
• The company expects to provide updates regarding any material strategic developments, initiatives, or changes through future filings, earnings communications, or other public disclosures.
• Coty will continue re-accelerating cost reduction efforts to deliver approximately $80.0 million in savings in fiscal 2026.
• The company plans to continue pursuing opportunities to reduce debt, including refinancing, issuing new notes, and redeeming/repurchasing outstanding debt with near-term maturities.
• The company expects to consider any future resumption of common stock dividends in line with achieving a Net debt to Adjusted EBITDA target of 2x.
• The Brazilian tax assessment case for the Gois State tax ICMS (Protege Fee) is expected to be heard in the first half of fiscal 2027.

Key Dates

Recommendation

Coty's Q2 fiscal 2026 results present a mixed picture. While the company successfully executed significant debt reduction and refinancing, improving its balance sheet and liquidity, the core operational performance shows considerable weakness. The substantial net loss, declining operating income, and gross margin pressure, particularly in the Consumer Beauty segment, are concerning. The ongoing strategic review under the new Interim CEO introduces uncertainty but also potential for future improvements. Given the current operational headwinds and the transitional phase, a 'hold' recommendation is appropriate. Investors should monitor the outcome of the strategic review and the effectiveness of cost reduction efforts, as well as the impact of tariffs and competitive market dynamics, before making further investment decisions. The deleveraging is a positive step, but the underlying business needs to demonstrate a clear path to sustainable profitability.

Keywords

Beauty Products, Fragrance, Color Cosmetics, Skincare, SEC Filing, 10-Q, Financial Results, Operating Income, Net Loss, Wella Sale, Debt Deleveraging, Management Change, Tariffs, Supply Chain, Market Trends, Share Repurchase, Legal Proceedings, Brazil Tax Assessments, Coty Inc.